Holen Sie sich die Stockscreener-App
30.24
1.31%
0.39
Handel nachbörslich:
30.24
Schlusskurs vom Vortag:
$29.85
Offen:
$29.44
24-Stunden-Volumen:
926.82K
Relative Volume:
0.77
Marktkapitalisierung:
$2.65B
Einnahmen:
$23.38M
Nettoeinkommen (Verlust:
$-155.22M
KGV:
-13.81
EPS:
-2.19
Netto-Cashflow:
$-134.36M
1W Leistung:
-5.08%
1M Leistung:
+12.33%
6M Leistung:
+69.60%
1J Leistung:
+0.83%
1-Tages-Spanne:
$28.84
$30.45
1-Wochen-Bereich:
$28.84
$32.02
52-Wochen-Spanne:
$13.45
$33.64
Ideaya Biosciences Inc Stock (IDYA) Company Profile
Firmenname
Ideaya Biosciences Inc
Sektor
Branche
Telefon
650-443-6209
Adresse
5000 SHORELINE CT, SUITE 300, SOUTH SAN FRANCISCO, CA
Vergleichen Sie IDYA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
IDYA
Ideaya Biosciences Inc
|
30.24 | 2.62B | 23.38M | -155.22M | -134.36M | -2.19 |
|
VRTX
Vertex Pharmaceuticals Inc
|
409.47 | 105.61B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
657.53 | 67.99B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
442.70 | 58.19B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
854.65 | 52.40B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.70 | 39.60B | 447.02M | -1.18B | -906.14M | -6.1812 |
Ideaya Biosciences Inc Stock (IDYA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-09-18 | Eingeleitet | Guggenheim | Buy |
| 2025-09-04 | Eingeleitet | Barclays | Overweight |
| 2025-09-04 | Eingeleitet | Citizens JMP | Mkt Outperform |
| 2025-07-22 | Eingeleitet | TD Cowen | Buy |
| 2025-07-10 | Fortgesetzt | Goldman | Neutral |
| 2025-06-26 | Eingeleitet | Wells Fargo | Overweight |
| 2024-11-18 | Eingeleitet | Stephens | Overweight |
| 2024-11-05 | Herabstufung | Leerink Partners | Outperform → Market Perform |
| 2024-10-24 | Eingeleitet | UBS | Buy |
| 2024-10-15 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2024-07-08 | Eingeleitet | Mizuho | Outperform |
| 2024-03-08 | Eingeleitet | BTIG Research | Buy |
| 2023-08-08 | Eingeleitet | SVB Securities | Outperform |
| 2023-05-24 | Eingeleitet | Goldman | Buy |
| 2023-04-24 | Hochstufung | Stifel | Hold → Buy |
| 2023-03-23 | Eingeleitet | Berenberg | Buy |
| 2023-02-28 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2022-12-28 | Eingeleitet | CapitalOne | Overweight |
| 2022-10-27 | Eingeleitet | Citigroup | Buy |
| 2022-08-15 | Herabstufung | Stifel | Buy → Hold |
| 2022-07-18 | Fortgesetzt | Oppenheimer | Outperform |
| 2022-03-10 | Hochstufung | Stifel | Hold → Buy |
| 2021-09-23 | Eingeleitet | Stifel | Hold |
| 2021-06-04 | Fortgesetzt | Robert W. Baird | Outperform |
| 2021-03-11 | Eingeleitet | Guggenheim | Buy |
| 2020-10-07 | Eingeleitet | Wedbush | Outperform |
| 2020-09-01 | Eingeleitet | Northland Capital | Outperform |
| 2020-07-13 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2020-06-17 | Bestätigt | H.C. Wainwright | Buy |
| 2020-04-06 | Eingeleitet | H.C. Wainwright | Buy |
| 2020-03-13 | Eingeleitet | ROTH Capital | Buy |
| 2019-10-17 | Eingeleitet | Oppenheimer | Outperform |
| 2019-09-10 | Eingeleitet | Robert W. Baird | Outperform |
| 2019-06-17 | Eingeleitet | Citigroup | Buy |
| 2019-06-17 | Eingeleitet | JP Morgan | Neutral |
| 2019-06-17 | Eingeleitet | Jefferies | Buy |
Alle ansehen
Ideaya Biosciences Inc Aktie (IDYA) Neueste Nachrichten
Will IDEAYA Biosciences Inc. stock see PE expansionWeekly Trade Recap & Verified Momentum Watchlists - newser.com
Using AI based signals to follow IDEAYA Biosciences Inc.Weekly Trend Summary & Target Return Focused Picks - newser.com
Is IDEAYA Biosciences Inc. stock in correction or buying zoneWeekly Stock Recap & Real-Time Volume Analysis - newser.com
(IDYA) Price Dynamics and Execution-Aware Positioning - news.stocktradersdaily.com
Why IDEAYA Biosciences Inc. stock appeals to analystsMarket Sentiment Review & Growth Focused Stock Pick Reports - newser.com
How IDEAYA Biosciences Inc. stock reacts to Fed rate cutsQuarterly Growth Report & Accurate Intraday Trading Signals - newser.com
Is IDEAYA Biosciences Inc. stock a top momentum playMarket Trend Review & AI Driven Stock Reports - newser.com
Will IDEAYA Biosciences Inc. (30J) stock hit analyst forecastsInflation Watch & Technical Pattern Based Buy Signals - newser.com
Using flow based indicators on IDEAYA Biosciences Inc.July 2025 Decliners & High Conviction Buy Zone Picks - newser.com
Will IDEAYA Biosciences Inc. (30J) stock extend growth storyQuarterly Risk Review & Real-Time Volume Trigger Notifications - newser.com
Is IDEAYA Biosciences Inc. stock entering bullish territoryStop Loss & High Conviction Investment Ideas - newser.com
Institutional scanner results for IDEAYA Biosciences Inc.Profit Target & Fast Moving Trade Plans - newser.com
Will IDEAYA Biosciences Inc. stock remain a Wall Street favorite2025 Price Targets & Verified Chart Pattern Signals - newser.com
News impact scoring models applied to IDEAYA Biosciences Inc.Market Growth Report & Fast Gain Stock Tips - newser.com
Is IDEAYA Biosciences Inc. stock affected by interest rate hikes2025 Risk Factors & Short-Term High Return Ideas - fcp.pa.gov.br
IDEAYA Biosciences (NASDAQ:IDYA) Announces Earnings Results, Beats Estimates By $1.45 EPS - MarketBeat
IDEAYA Biosciences Turns a Profit in Q3 on Servier Partnership Revenue - MSN
Order flow analysis tools used on IDEAYA Biosciences Inc.Swing Trade & Accurate Intraday Trading Signals - newser.com
What MACD signals say about IDEAYA Biosciences Inc.July 2025 Recap & Safe Capital Growth Stock Tips - newser.com
IDEAYA Biosciences Inc. stock trend forecastWeekly Trend Summary & Long Hold Capital Preservation Tips - newser.com
Can IDEAYA Biosciences Inc. (30J) stock attract ESG investmentsCPI Data & High Return Stock Watch Alerts - newser.com
IDEAYA Biosciences Reports Strong Q3 2025 Results - TipRanks
[10-Q] IDEAYA Biosciences, Inc. Quarterly Earnings Report | IDYA SEC FilingForm 10-Q - Stock Titan
Ideaya Biosciences Reports Q3 Net Income, Revenue - MarketScreener
IDEAYA Biosciences Delivers Earnings Surprise And Raises Guidance - Finimize
IDEAYA Biosciences Inc reports results for the quarter ended September 30Earnings Summary - TradingView
IDEAYA Biosciences posts Q3 profit on Servier deal revenue By Investing.com - Investing.com UK
IDEAYA Biosciences posts Q3 profit on Servier deal revenue - Investing.com
IDEAYA Biosciences Q3 net income beats estimates - MarketScreener
Earnings Flash (IDYA) IDEAYA Biosciences, Inc. Reports Q3 Revenue $207.8M, vs. FactSet Est of $6.3M - MarketScreener
[8-K] IDEAYA Biosciences, Inc. Reports Material Event | IDYA SEC FilingForm 8-K - Stock Titan
IDEAYA Biosciences Reports Third Quarter 2025 Financial Results and Provides Business Update - PR Newswire
How to integrate IDEAYA Biosciences Inc. into portfolio analysis toolsEarnings Recap Summary & Daily Entry Point Alerts - newser.com
Finanzdaten der Ideaya Biosciences Inc-Aktie (IDYA)
Umsatz
Nettogewinn
Free Cashflow
ENV
5.44%
0.70%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):